Cash Flow Statement
Growth Metrics

Harvard Bioscience (HBIO) Net Cash Flow Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (1y) (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn -342.50%
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 131.47%
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn -40.20%
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn -194.15%
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn -
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 460.71%
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 84.02%
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 144.81%
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn -62.65%
10 Harvard Bioscience 25.38 Mn 18.29 Mn 12.24 Mn -217.47%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -217.47%
Dec 31, 2025 1,889.80%
Sep 30, 2025 -458.94%
Jun 30, 2025 699.05%
Mar 31, 2025 793.50%
Dec 31, 2024 88.79%
Sep 30, 2024 -87.52%
Jun 30, 2024 -138.22%
Mar 31, 2024 115.51%
Dec 31, 2023 -205.59%
Sep 30, 2023 107.19%
Jun 30, 2023 145.62%
Mar 31, 2023 66.44%
Dec 31, 2022 -112.15%
Sep 30, 2022 189.43%
Jun 30, 2022 -427.03%
Mar 31, 2022 1.75%
Dec 31, 2021 -57.47%
Sep 30, 2021 -916.25%
Jun 30, 2021 111.53%
Mar 31, 2021 1.47%
Dec 31, 2020 314.46%
Sep 30, 2020 -96.26%
Jun 30, 2020 -2,260.29%
Mar 31, 2020 22.41%
Dec 31, 2019 -17.18%
Sep 30, 2019 111.57%
Jun 30, 2019 -1,006.67%
Mar 31, 2019 -533.00%
Dec 31, 2018 202.09%
Sep 30, 2018 -13.37%
Jun 30, 2018 111.19%
Mar 31, 2018 55.06%
Dec 31, 2017 -212.07%
Sep 30, 2017 -37.73%
Jun 30, 2017 77.02%
Mar 31, 2017 50.78%
Dec 31, 2016 1,929.87%
Sep 30, 2016 262.11%
Jun 30, 2016 32.60%
Mar 31, 2016 57.23%
Dec 31, 2015 99.37%
Sep 30, 2015 -177.90%
Jun 30, 2015 -347.85%
Mar 31, 2015 -18,664.29%
Dec 31, 2014 -4.42%
Sep 30, 2014 -23.82%
Jun 30, 2014 -96.58%
Mar 31, 2014 -100.73%
Dec 31, 2013 -6,452.17%
Sep 30, 2013 55.22%
Jun 30, 2013 762.75%
Mar 31, 2013 1,374.67%
Dec 31, 2012 -90.84%
Sep 30, 2012 125.44%
Jun 30, 2012 -23.17%
Mar 31, 2012 2.28%
Dec 31, 2011 -34.68%
Sep 30, 2011 -870.78%